SIP
KITE

Stoneridge Investment Partners’s Kite Pharma, Inc. KITE Stock Holding History

Stoneridge Investment Partners’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-28,772
Closed -$1.6M – 329
2015
Q3 		$1.6M Sell
28,772
-35,926
-56% -$2.26M 0.22% 126
2015
Q2 		$3.94M Sell
64,698
-16,629
-20% -$949K 0.49% 53
2015
Q1 		$4.69M Buy
+81,327
New +$5.45M 0.55% 52

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stoneridge Investment Partners's KITE Position: Q4 2015 in Review

Stoneridge Investment Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2015, closing a stake of 28,772 shares — an estimated $1.6M sold.

Stoneridge Investment Partners first reported a position in KITE in Q1 2015 and held it in 3 quarters. The position peaked at $4.69M in Q1 2015. 187 funds tracked by Wall St. Rank hold KITE as of Q4 2015.

  • Stoneridge Investment Partners reported no remaining Kite Pharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • Stoneridge Investment Partners sold 28,772 Kite Pharma, Inc. shares in Q4 2015, an estimated $1.6M.
  • Stoneridge Investment Partners first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 3 quarters.
  • Stoneridge Investment Partners's Kite Pharma, Inc. position peaked at $4.69M in Q1 2015.
  • 187 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2015.

Based on Stoneridge Investment Partners's 13F filing for Q4 2015, filed 4 Feb 2016.